Mesalamine Tablet, Delayed Release
Product Images NDC 0527-3012

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0527-3012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120s (120s)

Label for Mesalamine Delayed-Release Tablets, USP, each containing 1.2 g of mesalamine. The label indicates a once-daily oral dosage form, with 120 tablets per container. It includes storage instructions, manufacturer details (Haimen Pharma Inc., China), and distributor Lannett Company Inc., Philadelphia, PA. The label features a barcode and the product NDC 0527-3012.*

FDA Label Image

Structure (Chemicalstructure)

Chemical structure diagram of mesalamine, showing a benzene ring with hydroxyl, amino, and carboxyl functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.